| COMPANY NAME | GYNOFEM HEALTHCARE AND PHARMACEUTICALS LIMITED |
|---|---|
| NATURE OF BUSINESS | PHARMACEUTICALS |
| ISIN NO | INE0NLL01017 |
| FACE VALUE | Rs.1/- |
| PROMOTERS | NISHI KANT JOSHI, ANURAG MENDHE, KARTIKAY JOSHI |
| COMPANY WEBSITE | www.gynofemhealthcare.com |
| YEAR OF ESTABLISHMENT | 2016 |
| REGISTERED ADDRESS | 75/2/16, S.K. COMPOUND, LASUDIYA MORI, DEWAS NAKA, INDORE, MADHYA PRADESH – 452010 |
Gynofem Healthcare and Pharmaceuticals Limited is a fast-growing Indian pharmaceutical company dedicated to women's healthcare. The company specializes in the development and marketing of products aimed at Gynaecology, Obstetrics, and Infertility
Its core mission is to support maternal health, assisting women from the conception stage through pregnancy and postpartum recovery. Since its transition to a Public Limited Company in late 2022, Gynofem has significantly scaled its institutional framework, focusing on R&D to address hormonal imbalances and malnutrition among mothers and children. The company operates a GMP-certified manufacturing facility in Baddi, Himachal Pradesh.
They operate under strict compliance with ISO 9001:2015, GMP (Good Manufacturing Practices), and GLP (Good Laboratory Practices). A significant portion of the 2024-25 budgets was allocated to developing bio-equivalent generics for complex hormonal treatments, aiming to provide affordable alternatives to expensive imported brands. Historically strong in Madhya Pradesh and Maharashtra, the company is currently appointing new "Super Stockists" in North and South India to achieve a truly national footprint by 2026.
On digital healthcare there are ongoing efforts to integrate their product range into e-pharmacy platforms like 1mg, Apollo Pharmacy, and Tata 1mg to capture the growing urban demand for women's wellness products